Martino Ruggieri
Citata da
Citata da
The clinical and diagnostic implications mosaicism in the neurofibromatoses
M Ruggieri, SM Huson
Neurology 56 (11), 1433-1443, 2001
Clinical features and viral serologies in children with multiple sclerosis: a multinational observational study
B Banwell, L Krupp, J Kennedy, R Tellier, S Tenembaum, J Ness, ...
The Lancet Neurology 6 (9), 773-781, 2007
Gross deletions of the neurofibromatosis type 1 (NF1) gene are predominantly of maternal origin and commonly associated with a learning disability, dysmorphic …
M Upadhyaya, M Ruggieri, J Maynard, M Osborn, C Hartog, S Mudd, ...
Human genetics 102, 591-597, 1998
Infantile spasms syndrome, West syndrome and related phenotypes: what we know in 2013
P Pavone, P Striano, R Falsaperla, L Pavone, M Ruggieri
Brain and development 36 (9), 739-751, 2014
Multiple sclerosis in children under 6 years of age
M Ruggieri, A Polizzi, L Pavone, LME Grimaldi
Neurology 53 (3), 478-478, 1999
AMPA receptor GluA2 subunit defects are a cause of neurodevelopmental disorders
V Salpietro, CL Dixon, H Guo, OD Bello, J Vandrovcova, S Efthymiou, ...
Nature communications 10 (1), 3094, 2019
The different forms of neurofibromatosis
M Ruggieri
Child's Nervous System 15, 295-308, 1999
Apparent preferential loss of heterozygosity at TSC2 over TSC1 chromosomal region in tuberous sclerosis hamartomas
C Carbonara, L Longa, E Grosso, G Mazzucco, C Borrone, ML Garrè, ...
Genes, Chromosomes and Cancer 15 (1), 18-25, 1996
The neurology of coeliac disease in childhood: what is the evidence? A systematic review and meta‐analysis
E Lionetti, R Francavilla, P Pavone, L Pavone, T Francavilla, A Pulvirenti, ...
Developmental Medicine & Child Neurology 52 (8), 700-707, 2010
Topical review: Hypomelanosis of Ito: clinical syndrome or just phenotype?
M Ruggieri, L Pavone
Journal of Child Neurology 15 (10), 635-644, 2000
Earliest clinical manifestations and natural history of neurofibromatosis type 2 (NF2) in childhood: a study of 24 patients
M Ruggieri, P Iannetti, A Polizzi, I La Mantia, A Spalice, O Giliberto, ...
Neuropediatrics 36 (01), 21-34, 2005
Different roles of matrix metalloproteinases-2 and-9 after human ischaemic stroke
V Lucivero, M Prontera, DM Mezzapesa, M Petruzzellis, M Sancilio, ...
Neurological Sciences 28, 165-170, 2007
Germline and somatic NF1 gene mutation spectrum in NF1‐associated malignant peripheral nerve sheath tumors (MPNSTs)
M Upadhyaya, L Kluwe, G Spurlock, B Monem, E Majounie, ...
Human mutation 29 (1), 74-82, 2008
Multiple sclerosis in children under 10 years of age
M Ruggieri, P Iannetti, A Polizzi, L Pavone, LME Grimaldi*
Neurological Sciences 25, s326-s335, 2004
Characterization of the somatic mutational spectrum of the neurofibromatosis type 1 (NF1) gene in neurofibromatosis patients with benign and malignant tumors
M Upadhyaya, S Han, C Consoli, E Majounie, M Horan, NS Thomas, ...
Human mutation 23 (2), 134-146, 2004
Gluten psychosis: confirmation of a new clinical entity
E Lionetti, S Leonardi, C Franzonello, M Mancardi, M Ruggieri, C Catassi
Nutrients 7 (7), 5532-5539, 2015
West syndrome: a comprehensive review
P Pavone, A Polizzi, SD Marino, G Corsello, R Falsaperla, S Marino, ...
Neurological Sciences 41, 3547-3562, 2020
Ohtahara syndrome with emphasis on recent genetic discovery
P Pavone, A Spalice, A Polizzi, P Parisi, M Ruggieri
Brain and Development 34 (6), 459-468, 2012
Epilepsy is not a prominent feature of primary autism
P Pavone, G Incorpora, A Fiumara, E Parano, RR Trifiletti, M Ruggieri
Neuropediatrics 35 (04), 207-210, 2004
Childhood neurofibromatosis type 2 (NF2) and related disorders: from bench to bedside and biologically targeted therapies
M Ruggieri, AD Praticò, A Serra, L Maiolino, S Cocuzza, P Di Mauro, ...
Acta Otorhinolaryngologica Italica 36 (5), 345, 2016
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20